Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · IEX Real-Time Price · USD
5.60
-0.22 (-3.78%)
Dec 2, 2022 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Selling, General & Admin
7.281.350.93
Research & Development
12.3188.58
Operating Expenses
19.589.359.5
Operating Income
-19.58-9.35-9.5
Other Expense / Income
81.02-2.02-1.6
Pretax Income
-100.61-7.33-7.91
Net Income
-100.61-7.33-7.91
Preferred Dividends
00-0.22
Net Income Common
-100.61-7.33-7.69
Shares Outstanding (Basic)
2000
Shares Outstanding (Diluted)
2000
Shares Change
4685.59%-2.71%-
EPS (Basic)
-5.02-17.48-17.84
EPS (Diluted)
-5.02-17.48-17.84
Free Cash Flow Per Share
-0.90-17.77-15.83
EBITDA
-100.6-7.33-7.91
Depreciation & Amortization
000
EBIT
-100.61-7.33-7.91
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).